Table 1 |
||||||
|
Disease-causing mutations in the cathepsin C gene detected so far. |
||||||
|
Sl# |
Exon |
Type |
Mutation |
Effect |
Origin / Disease |
No. of families |
|
|
||||||
|
1 |
1 |
Nonsense |
c.72C>A (p.C24X) |
Premature stop |
Moroccan 19 / PLS |
1 |
|
2 |
1 |
Nonsense |
c.96T>G (p.Y32X) |
Premature stop |
Mexican 20, §Caucasian 20, French 19 / PLS |
3 |
|
3 |
1 |
Nonsense |
c.145C>T (p.Q49X) |
Premature stop |
Indian A / PLS |
1 |
|
4 |
1 |
Missense |
c.116G>C (p.W39S) |
AHCR** |
Puerto Rican 16 / PLS |
1 |
|
5 |
2 |
Nonsense |
c.205C>T (p.Q69X) |
Premature stop |
Indian A / PLS |
1 |
|
6 |
2 |
Deletion |
c.199_222del (p. 67_74) |
Frameshift |
* Chinese 15 / PLS |
1 |
|
7 |
3 |
Missense |
c.380A>C (p. H127P) |
AHCR** |
French 19 / PLS |
1 |
|
8 |
3 |
Missense |
c.415G>A (p.G139R) |
AHCR** |
§S Caucasian 20 / PLS |
1 |
|
9 |
3 |
Insertion |
c.445_446insATGT (p.V149fsX157) |
Frameshift & premature stop |
Indian 15 / PLS |
1 |
|
10 |
Splice site (Intron 3) |
IVS3_1G>A |
Altered splicing |
Egyptian 7, Jordanian 22 / PLS |
2 |
|
|
11 |
4 |
Nonsense |
c.545G>A (p.W185X) |
Premature stop |
Brazilian 21 / PLS |
1 |
|
12 |
4 |
Missense |
c.587T>C (p.L196P) |
AHCR** |
Brazilian 3 / PLS |
1 |
|
13 |
4 |
Insertion |
622_623insC (p.H208fsX223) |
Frameshift & Premature stop |
Turkish 15 / PLS |
1 |
|
14 |
4 |
Nonsense |
c.628C>T (p.R210X) |
Premature stop |
Lebanese7, Algerian 19 / PLS |
2 |
|
15 |
5 |
Nonsense |
c.704G>A (p.W235X) |
Premature stop |
Iranian 15 / PLS |
1 |
|
16 |
5 |
Missense |
c.706G>T (p.D236Y) |
AHCR** |
φ Spanish 18 / PLS |
1 |
|
17 |
5 |
Deletion |
c.711del14 |
Frameshift & Premature stop |
Algerian 19 / PLS |
1 |
|
18 |
5 |
Missense |
c.745G>T (p.V249F) |
AHCR** |
Indian-Pakistani 7 / PLS |
1 |
|
19 |
5 |
Nonsense |
c.748C>T (p.R250X) |
Premature stop |
Turkish 15 / PLS |
1 |
|
20 |
5 |
Missense |
c.755A>T (p.Q252L) |
AHCR** |
Egyptian 7 / PLS |
1 |
|
21 |
6 |
Missense |
c.815G>C (p.R272P) |
AHCR** |
Lebanese7, Turkish 15, §Caucasian20, (4) Saudi 17, Holland19, French 19 / PLS |
9 |
|
22 |
6 |
Nonsense |
c.856C>T (p.Q286X) |
Premature stop |
Turkish 9,14,17 / PLS |
3 |
|
23 |
6 |
Missense |
c.857A>G (p.Q286R) |
AHCR** |
Indian 9, Spanish18 / HMS, PLS |
2 |
|
24 |
6 |
Missense |
c.872G>A (p.C291Y) |
AHCR** |
φ Spanish 18 /PLS |
1 |
|
25 |
7 |
Missense |
c.898G>A (p.G300S) |
AHCR** |
Φ Vietnamese 15 / PLS |
1 |
|
26 |
7 |
Missense |
c.899G>A (p.G300D) |
AHCR** |
Saudi 17 / PLS |
1 |
|
27 |
7 |
Missense |
c.901G>A (p.G301S) |
AHCR** |
Indian-Pakistani 7, Iranian 15, Japanese 16 / PLS |
3 |
|
28 |
7 |
Missense |
c.902G>T (p.G301V) |
AHCR** |
Iranian 15 / PLS |
1 |
|
29 |
7 |
Missense |
c.910T>A (p.Y304N) |
AHCR** |
Panamanian 15 / PLS |
1 |
|
30 |
7 |
Nonsense |
c.912C>A (p.Y304X) |
Premature stop |
Indian A / PLS |
1 |
|
31 |
7 |
Missense |
c.956A>G (p.E319G) |
AHCR** |
Iranian 15 / PLS |
1 |
|
32 |
7 |
Deletion |
c.984del7 |
Frameshift & Premature stop |
French 19 / PLS |
1 |
|
33 |
7 |
Missense |
c.1015C>T (p.R339C) |
AHCR** |
Egyptian 7,15, Turkish10, Martinique 19 / PLS |
4 |
|
34 |
7 |
Deletion |
c.1028_1029delCT (p.S343X) |
Frameshift & Premature stop |
Turkish 14 / PLS |
1 |
|
35 |
7 |
Missense |
c.1040A>G (p.Y347C) |
AHCR** |
Indian-Pakistani7, Jordanian 10 / PLS, PPP |
2 |
|
36 |
7 |
Deletion |
c.1047delA (p.G349fsX359) |
Frameshift & Premature stop |
Turkish 14 / PLS |
1 |
|
37 |
7 |
Deletion |
c.1056delT |
Frameshift & Premature stop |
French 19 / PLS |
1 |
|
38 |
7 |
Deletion |
c.1141delC (p.L381fsX393) |
Frameshift & Premature stop |
§S Caucasian20, French 19 / PLS |
2 |
|
39 |
7 |
Nonsense |
c.1286G>A (p.W429X) |
Premature stop |
Turkish 14,15 / PLS |
4 |
|
40 |
7 |
Missense |
c.1287G>C (p. W429C) |
AHCR** |
French19 / PLS |
1 |
|
41 |
7 |
Missense |
c.1360A>G (p.E447G) |
AHCR** |
Φ Vietnamese 15 / PLS |
1 |
|
|
||||||
|
[A] Novel mutations identified in this study; [20] Zhang et al. 2002; [16] Nakano et al. 2001; [15] Hart et al. 2000c; [17] Zhang et al. 2001; [18] Allende et al. 2001; [19] Lefevre et al. 2001; [7]Toomes et al. 1999; [3] Cury et al. 2002; [21] Hart et al. 2002; [10] Hart et al. 2000b; [14] Hart et al. 1999; [22] Nusier et al. 2002; [9] Hart et al. 2000a. * Proband was a compound heterozygote for the 199–222 del and 458C>T mutations ** Alteration of highly conserved residue. §Probands were compound heterozygote for the 96T>G and 815G>C mutations. §S Proband was a compound heterozygote for the 415G>A and 1141delC mutations. φ Proband was a compound heterozygote for the 706G>T and 872G>A mutations. Φ Proband was a compound heterozygote for the 898G>A and 1360A>G mutations. |
||||||
|
Selvaraju et al. BMC Medical Genetics 2003 4:5 doi:10.1186/1471-2350-4-5 |
||||||